[ad_1]
The IPO market is becoming hot. In the coming week, the IPO process of Evergrande Property, JD Health, Blue Moon and other key IPOs, totaling over HK $ 70 billion, will begin. According to overseas news, many other companies have passed the listing hearing, including trendy toy maker Bubble Mart, and will begin investing training this week.
To track IPO news, you can browse 【IPO IPO】
IPO of Evergrande property on Monday
Evergrande Property (new listing code: 06666) expects to sell approximately 1.621 billion shares, reaching a maximum of approximately 15.8 billion yuan. The offer price ranges from 8.5 yuan to 9.75 yuan. The entry fee for one lot (500 shares) is 4924 yuan. Sunday) through Thursday (26) IPO and plans to go public on December 2.
The group introduced 23 key investors, including strategic investors such as AI company SenseTime (SenseTime), China Gas (00384), China Merchants Capital, etc., who have subscribed for a total of 7.2 billion Hong Kong dollars. 48.7% of the total.
Evergrande Property expects to issue 15% of its shares with a P / E ratio of 20.5 to 23.5 times in 2021, with a market value of up to $ 13.3 billion (approximately $ 103.7 billion Hong Kong).
The IPO of the relay also includes JD Health, Blue Moon, China Resources Vientiane Life, Jiayuan Service, Netjoy, a service provider of short video marketing solutions, and the mainland real estate sector, raising at least 70 billion yuan.
Additionally, Sino-Ocean Services, Bubble Mart and Hebo Pharma all passed the listing hearing last Thursday and plan to launch the pre-IPO roadshow next Monday. The three new shares will raise a total of $ 900 million (approximately HK $ 7.02 billion).
Bubble Mart sells mainly trendy toys
Among them, Bubble Mart expects to raise US $ 200 million to $ 300 million (up to 2.34 billion yuan). Joint sponsors are Morgan Stanley and CLSA. The company was founded in 2010 and mainly sells fashion toys, electronics and beauty products and designs “blind box” toys by itself.
Pao Mart currently operates more than 100 offline stores and more than 800 robotics stores across the country. As of last year, net profit recorded 451 million yuan, an increase of 3.5 times year on year; turnover was 2.27 times year-on-year to 1.68 billion yuan. The main source of income came from retail stores and online channels.
Additionally, mainland clinical stage biopharmaceutical companies and platinum medicine expect to raise up to US $ 300 million (approximately Hong Kong US $ 2.34 billion). Morgan Stanley, Bank of America and CITIC Lyon are joint sponsors.
[Nuova IPO azionaria]Mainland real estate mainland raises about $ 1.56 billion in fastest month-end IPO [New Stock IPO]Deqi Pharmaceuticals 6996 rose 1.1% for the first time and earned 100 yuan in one hand “China will become the second largest pharmacy in the world after the United States”Author: Xie Zhuorong
[ad_2]
Source link
